Revealing the metabolic sites of atazanavir in human by parallel administrations of D-atazanavir analogs.

about

Revealing the metabolic sites of atazanavir in human by parallel administrations of D-atazanavir analogs.

Item

http://www.wikidata.org/entity/Q42265837

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Revealing the metabolic sites ...... tions of D-atazanavir analogs.

@en

Revealing the metabolic sites ...... tions of D-atazanavir analogs.

@nl

type

Item

label

Revealing the metabolic sites ...... tions of D-atazanavir analogs.

@en

Revealing the metabolic sites ...... tions of D-atazanavir analogs.

@nl

prefLabel

Revealing the metabolic sites ...... tions of D-atazanavir analogs.

@en

Revealing the metabolic sites ...... tions of D-atazanavir analogs.

@nl

P1476

Revealing the metabolic sites ...... tions of D-atazanavir analogs.

@en

P2093

Changfu Cheng

http://www.w3.org/2001/XMLSchema#string

Lijun Wu

http://www.w3.org/2001/XMLSchema#string

Roger Tung

http://www.w3.org/2001/XMLSchema#string

Scott Harbeson

http://www.w3.org/2001/XMLSchema#string

Sunanda Vedananda

http://www.w3.org/2001/XMLSchema#string

Virginia Braman

http://www.w3.org/2001/XMLSchema#string

P2860

Liquid chromatographic assay for the protease inhibitor atazanavir in plasma.

Molecular basis for increased susceptibility of isolates with atazanavir resistance-conferring substitution I50L to other protease inhibitors.

CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism.

Atazanavir metabolism according to CYP3A5 status: an in vitro-in vivo assessment.

Atazanavir: a review of its use in the management of HIV-1 infection.

Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults.

Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572.

Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection

Atazanavir.

Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents.

P304

1019-1031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMS.3247

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24078243

http://www.w3.org/2001/XMLSchema#string